arrow
R

Roselena Silvestri Schuh

hospital de clínicas de porto alegre
H指数:19
被引数:1,208
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I

脂质体CRISPR/Cas9介导的局部基因组编辑在黏多糖贮积症I型关节疾病中的应用

2026-02-260
OAAI
Nanoemulsions as carriers for malignant brain tumors treatment: a scoping review on drugs, natural compounds, and siRNA delivery

纳米乳液作为恶性脑肿瘤治疗的载体:关于药物、天然化合物和siRNA递送的范畴综述

2025-11-010
PRE
An overview of the potentialities and recent advances in nanotechnology-based systems for glucocorticoids delivery

纳米技术为基础的糖皮质激素递送系统的潜力概述及最新进展

2025-10-150
PRE
Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

中枢神经系统疾病鼻腔给药基因递送的研究进展

2025-09-100
OAAI
Studies on the safety and irritability of eco-friendly extracts of Pterocaulon balansae Chodat (Asteraceae) standardized in coumarins aiming at topical application

关于Pterocaulon balansae Chodat(Asteraceae)生态友好型提取物(经香豆素标准化)安全性与刺激性研究,旨在用于局部应用

2025-05-180
PRE
Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice

新生小鼠经静脉注射脂质体CRISPR/Cas9复合物的实验中,未观察到脱靶效应或肿瘤发生。

2025-05-170
OA
Effects of chorionic mesenchymal stromal cells, their conditioned medium, and membrane particles on neutrophil functionality

绒毛膜间充质基质细胞、其条件培养基和膜颗粒对中性粒细胞功能的影响

2025-04-220
PRE
Evaluation of off-target events after an intravenous injection of liposomal CRISPR/Cas9 complex in vivo
2025-02-010
PRE
Laronidase-loaded liposomes reach the brain and other hard-to-treat organs after noninvasive nasal administration
2024-07-010
PRE
Topical Nanoemulsions as Delivery Systems for Green Extracts of Pterocaulon balansae Aiming at the Treatment of Sporotrichosis
2024-04-020
OAAI
Intra-articular administration of nonviral vectors aminh at mucopolysaccharidosis type I mice gene editing
2024-02-010
PRE
Bone disease in mucopolysaccharidosis type I: Morphological, structural and biomechanical characterization, and effect of different treatment approaches
2024-02-010
PRE
Nasal administration of laronidase-loaded liposomes aiming at mucopolysaccharidosis type I treatment
2023-02-010
PRE
Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis
2022-12-121
OAAI
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses

治疗溶酶体疾病的基因编辑策略: 粘多糖的例子

2022-12-017
PRE
Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system
2022-01-3113
PRE
In Situ Gene Therapy

原位基因治疗

2021-12-236
PRE
Gene Therapy of Mucopolysaccharidosis Type I Mice: Repeated Administrations and Safety Assessment of pIDUA/Nanoemulsion Complexes

I型粘多糖贮积症小鼠的基因治疗: pIDUA/纳米乳液复合物的重复给药和安全性评估

2021-12-236
PRE
Chitosan-coated rosmarinic acid nanoemulsion nasal administration protects against LPS-induced memory deficit, neuroinflammation, and oxidative stress in Wistar rats
2020-12-0128
OAAI
CD73 siRNA therapy regulates glioblastoma immune microenvironment
2019-12-010
PRE